Results 261 to 270 of about 98,807 (272)

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, S Nakamori, N Okano
exaly  

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Annals of Oncology, 2012
Dominique Genre, Patrice Viens, R Lamy   +2 more
exaly  

Pancreatic Cancer Chemoresistance to Gemcitabine

Cancers, 2017
Manoj Amrutkar, Amrutkar Manoj, Gladhaug Ivar P   +2 more
exaly  

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

Annals of Oncology, 2012
Silvia Stacchiotti, Roberta Sanfilippo, Elena Palassini   +2 more
exaly  

A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types

Journal of Controlled Release, 2007
Couvreur P, Didier Desmaële, L Harivardhan Reddy   +2 more
exaly  

Gemcitabine

Reactions Weekly, 2020
openaire   +1 more source

Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade

Cancer Letters, 2016
Hengqiang Zhao, Qiang Shen, Tao Yin
exaly  

Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study

Annals of Oncology, 2007
Roberto Labianca, C Louvet, A Hinke
exaly  

Clinical pharmacology and pharmacogenetics of gemcitabine

Drug Metabolism Reviews, 2009
Federico Innocenti, Wei Peng Yong, Andrea Wong   +2 more
exaly  

Gemcitabine

Reactions Weekly, 2008
openaire   +1 more source